{
    "root": "d15411d7-3140-41a5-8d97-c7cdc4443295",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "diltiazem hydrochloride",
    "value": "20250327",
    "ingredients": [
        {
            "name": "DILTIAZEM HYDROCHLORIDE",
            "code": "OLH94387TE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_645509"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER",
            "code": "NX76LV5T8J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "AMMONIO METHACRYLATE COPOLYMER TYPE A",
            "code": "8GQS4E66YY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25218"
        },
        {
            "name": "AMMONIO METHACRYLATE COPOLYMER TYPE B",
            "code": "161H3B14U2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25218"
        },
        {
            "name": "ETHYLCELLULOSE, UNSPECIFIED",
            "code": "7Z8S9VYZ4B"
        },
        {
            "name": "DIETHYL PHTHALATE",
            "code": "UF064M00AF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_34698"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_181906"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        }
    ],
    "indications": {
        "text": "diltiazem hydrochloride extended-release capsules indicated treatment hypertension . may used alone combination antihypertensive medications . diltiazem hydrochloride extended-release capsules indicated management chronic stable angina angina due coronary artery spasm .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "coronary artery spasm (DOID:11840)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11840"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic stable angina",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_458775"
            }
        ]
    },
    "contraindications": {
        "text": "patients controlled diltiazem alone combination medications may switched diltiazem hydrochloride extended-release capsules , usp nearest equivalent total daily dose . higher doses diltiazem hydrochloride extended-release capsules , usp may needed patients . monitor patients closely . subsequent titration higher lower doses may necessary . limited general experience doses 360 mg , doses 540 mg studied trials . incidence side effects increases dose increases first-degree av block , dizziness , sinus bradycardia bearing strongest relationship dose . hypertension : adjust individual patient needs . used monotherapy , reasonable starting doses 180 240 mg daily , although patients may respond lower doses . maximum antihypertensive effect usually observed 14 days chronic therapy ; therefore , schedule adjustments accordingly . usual range studied trials 240 360 mg daily . individual patients may respond higher doses 480 mg daily . angina : dosages treatment angina adjusted patient 's needs , starting dose 120 180 mg daily . individual patients may respond higher doses 480 mg daily . necessary , titration may carried 7- 14-day period .",
        "doid_entities": [
            {
                "text": "av block (DOID:0050820)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050820"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diltiazem hydrochloride extended-release capsules , usp 120mg capsule white imprinted n365 one end 120 end . medication supplied : bottles 30 capsules ndc 68788-7870-3 bottles 60 capsules ndc 68788-7870-6 bottles 90 capsules ndc 68788-7870-9 bottles 100 capsules ndc 68788-7870-1 bottles 120 capsules ndc 68788-7870-8 storage conditions : store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . avoid excessive humidity . revised : 01/2023 i0117 rev . b manufactured : ingenus pharmaceuticals , llc orlando , fl 32839-6408 made china repackaged : preferred pharmaceuticals inc .",
    "adverseReactions": "diltiazem hydrochloride extended-release capsules contraindicated ( 1 ) patients sick sinus syndrome except presence functioning ventricular pacemaker , ( 2 ) patients second- third-degree av block except presence functioning ventricular pacemaker , ( 3 ) patients hypotension ( less 90 mm hg systolic ) , ( 4 ) patients demonstrated hypersensitivity , ( 5 ) patients acute myocardial infarction pulmonary congestion documented x-ray admission .",
    "indications_original": "Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications.\n                  Diltiazem hydrochloride extended-release capsules are indicated for the management of chronic stable angina and angina due to coronary artery spasm.",
    "contraindications_original": "Patients controlled on diltiazem alone or in combination with other medications may be switched to diltiazem hydrochloride extended-release capsules, USP at the nearest equivalent total daily dose. Higher doses of diltiazem hydrochloride extended-release capsules, USP may be needed in some patients. Monitor patients closely. Subsequent titration to higher or lower doses may be necessary. There is limited general clinical experience with doses above 360 mg, but doses to 540 mg have been studied in clinical trials. The incidence of side effects increases as the dose increases with first-degree AV block, dizziness, and sinus bradycardia bearing the strongest relationship to dose.\n                  \n                     Hypertension: Adjust dosage to individual patient needs. When used as monotherapy, reasonable starting doses are 180 to 240 mg once daily, although some patients may respond to lower doses. Maximum antihypertensive effect is usually observed by 14 days of chronic therapy; therefore, schedule dosage adjustments accordingly. The usual dosage range studied in clinical trials was 240 to 360 mg once daily. Individual patients may respond to higher doses of up to 480 mg once daily.\n                  \n                     Angina: Dosages for the treatment of angina should be adjusted to each patient's needs, starting with a dose of 120 or 180 mg once daily. Individual patients may respond to higher doses of up to 480 mg once daily. When necessary, titration may be carried out over a 7- to 14-day period.",
    "warningsAndPrecautions_original": "Diltiazem hydrochloride Extended-Release Capsules, USP\n                  \n                  \n                     120mg Capsule is white and imprinted with N365 on one end and 120 on the other end.\n                  \n                  \n                     The medication is supplied in:\n                  \n                  \n                     \n                        \u00a0\n                        Bottles of 30 Capsules\tNDC 68788-7870-3\n                     \n                     \n                        \u00a0\n                        Bottles of 60 Capsules\tNDC 68788-7870-6\n                     \n                     \n                        \u00a0\n                        Bottles of 90 Capsules\tNDC 68788-7870-9\n                     \n                     \n                        \u00a0\n                        Bottles of 100 Capsules NDC 68788-7870-1\n                     \n                     \n                        \u00a0\n                        Bottles of 120 Capsules NDC 68788-7870-8\n                     \n                  \n                  \n                     Storage Conditions: Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature]. Avoid excessive humidity.\n                  \n                  Revised: 01/2023\n                  I0117\n                  Rev. B\n                  \n                     Manufactured for:\n                  \n                  Ingenus Pharmaceuticals, LLC\n                  Orlando, FL 32839-6408\n                  Made in China\n                  \n                  \n                     Repackaged By: Preferred Pharmaceuticals Inc.",
    "adverseReactions_original": "Diltiazem hydrochloride extended-release capsules are\u00a0contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker, (3) patients with hypotension (less than 90 mm Hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.",
    "drug": [
        {
            "name": "diltiazem hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_645509"
        }
    ]
}